Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Colette

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Diabetes Technology & Therapeutics|May 13, 2011
The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetesLouis Monnier, Anne Wojtusciszyn, Claude Colette, et al.
Diabetes Care|October 31, 2013
Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|September 21, 2021
Glycaemic variabilities: Key questions in pursuit of clarityL Ouis Monnier, David Owens, Claude Colette, et al.
Journal of Diabetes and Its Complications|January 10, 2015
"Mild dysglycemia" in type 2 diabetes: to be neglected or not?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|October 1, 2020
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overviewLouis Monnier, Jean-Louis Schlienger, Claude Colette, et al.
Diabetes Technology & Therapeutics|July 11, 2012
Add-on therapies to metformin in type 2 diabetes: what modulates the respective decrements in postprandial and basal glucose?Louis Monnier, Claude Colette, Andrea Comenducci, et al.
Diabetes Care|January 30, 2007
The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetesLouis Monnier, Claude Colette, Gareth J Dunseath, et al.
Diabetes & Metabolism|October 26, 2023
Key indices of glycaemic variability for application in diabetes clinical practiceLouis Monnier, Fabrice Bonnet, Claude Colette, et al.
The Journal of Laboratory and Clinical Medicine|May 6, 2005
Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cellsCristina De Oliveira, Claude Colette, Louis Monnier, et al.
Diabetes/Metabolism Research and Reviews|February 11, 2011
Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further studyLouis Monnier, Claude Colette, Françoise Michel, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Diabetes Technology & Therapeutics|May 13, 2011
The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetesLouis Monnier, Anne Wojtusciszyn, Claude Colette, et al.
Diabetes Care|October 31, 2013
Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|September 21, 2021
Glycaemic variabilities: Key questions in pursuit of clarityL Ouis Monnier, David Owens, Claude Colette, et al.
Journal of Diabetes and Its Complications|January 10, 2015
"Mild dysglycemia" in type 2 diabetes: to be neglected or not?Louis Monnier, Claude Colette, Sylvie Dejager, et al.
Diabetes & Metabolism|October 1, 2020
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overviewLouis Monnier, Jean-Louis Schlienger, Claude Colette, et al.
Diabetes Technology & Therapeutics|July 11, 2012
Add-on therapies to metformin in type 2 diabetes: what modulates the respective decrements in postprandial and basal glucose?Louis Monnier, Claude Colette, Andrea Comenducci, et al.
Diabetes Care|January 30, 2007
The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetesLouis Monnier, Claude Colette, Gareth J Dunseath, et al.
Diabetes & Metabolism|October 26, 2023
Key indices of glycaemic variability for application in diabetes clinical practiceLouis Monnier, Fabrice Bonnet, Claude Colette, et al.
The Journal of Laboratory and Clinical Medicine|May 6, 2005
Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cellsCristina De Oliveira, Claude Colette, Louis Monnier, et al.
Diabetes/Metabolism Research and Reviews|February 11, 2011
Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further studyLouis Monnier, Claude Colette, Françoise Michel, et al.
Pageof 3